Armata Pharmaceuticals, Inc. (ARMP) is a publicly traded company in the Unknown sector. Across all available filings, 4 corporate insiders have executed 10 transactions totaling $91.1M, demonstrating a bullish sentiment with $91.1M in net insider flow. The most recent transaction on Jul 10, 2025 involved a transaction of 13,637 shares valued at $31.0K.
No significant insider buying has been recorded for ARMP in the recent period.
No significant insider selling has been recorded for ARMP in the recent period.
Based on recent SEC filings, insider sentiment for ARMP is bullish with an Insider Alignment Score of 100/100 and a net flow of $91.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Armata Pharmaceuticals, Inc. (ARMP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 4 insiders are actively trading ARMP stock, having executed 10 transactions in the past 90 days. The most active insider is Inc. Innoviva, (Executive), who has made 3 transactions totaling $63.0M.
Get notified when executives and directors at ARMP file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 10, 2025 | Birx Deborah | Executive | Payment | 13,637 | $2.27 | $31.0K | |
| Mar 14, 2024 | Birx Deborah | Executive | Award | 60,000 | $N/A | $0 | |
| Mar 14, 2024 | Rychlik Richard | Executive | Award | 10,000 | $N/A | $0 | |
| Dec 21, 2023 | Birx Deborah | Executive | Award | 200,000 | $N/A | $0 | |
| Mar 31, 2022 | Innoviva, Inc. | Executive | Purchase | 5,385,208 | $5.00 | $26.9M | Large |
| Feb 9, 2022 | Opportunities Llc Innoviva Strategic | Executive | Purchase | 3,614,792 | $5.00 | $18.1M | Large |
| Oct 29, 2021 | Opportunities Llc Innoviva Strategic | Executive | Purchase | 1,212,122 | $3.30 | $4.0M | Large |
| Mar 17, 2021 | Innoviva, Inc. | Executive | Purchase | 4,285,935 | $3.25 | $13.9M | Large |
| Jan 26, 2021 | Opportunities Llc Innoviva Strategic | Executive | Purchase | 1,867,912 | $3.25 | $6.1M | Large |
| Mar 27, 2020 | Innoviva, Inc. | Executive | Purchase | 7,717,661 | $2.87 | $22.1M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 6 | $91.1M | 100.0% |
Payment(F) | 1 | $31.0K | 0.0% |
Award(A) | 3 | $0 | 0.0% |
Insiders at Armata Pharmaceuticals, Inc. are accumulating shares at an accelerated pace. With 4 insiders making 10 transactions totaling $91.1M in purchases versus $0 in sales, the net buying activity of $91.1M signals strong executive confidence. Inc. Innoviva, (Executive) leads the buying activity with $63.0M in transactions across all time.